Clinical trials: Postinflammatory Hyperpigmentation
Acne, Postinflammatory Hyperpigmentation
Efficacy of La Roche Posay Routine in the Management of Facial Post Inflammatory Hyperpigmentation (PIHP)
The goal of this clinical trial is to test and compare La Roche Posay routine --the studied product-- with a comparator product in participants with acne.
- Trial name
- PIHP (NCT06770127)
- Where
- Mauritius
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Cosmetique Active International
Postinflammatory Hyperpigmentation
Straberi Epistamp Device for Postinflammatory Hyperpigmentation
This pilot study will expand knowledge and application needling using the Straberi device for the improvement of Postinflammatory Hyperpigmentation (PIH) caused by acne.
- Trial name
- EPH (NCT04740255)
- Testing
- Straberi Epistamp
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Universal Skincare Institute
Postinflammatory Hyperpigmentation
Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris
The goal of this study is to determine if topical tranexamic acid is capable of decreasing the pigment of the dark spots left from acne bumps.
- Trial name
- NCT03361345
- Testing
- Tranexamic Acid, Vehicle
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- Wayne State University
Acne, Postinflammatory Hyperpigmentation
A Combination Treatment Reduces Acne Severity and PIHP
Acne is a chronic, inflammatory skin condition. It may cause scars and post-inflammatory hyperpigmentation (PIHP). PIHP frequently affects individuals with a phototype of IV or above.[1] PIHP is worsened by UV radiation, lasts…
- Trial name
- NCT05601960
- Testing
- anti-acne dermocosmetic
- Where
- United Arab Emirates
- Volunteers
- 1,785 people
- Sponsor
- Cosmetique Active International
Hyperpigmentation; Postinflammatory
Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation
Post-inflammatory hyperpigmentation is a common pigmentary skin disorder that is refractory to treatment. The treatment for postinflammatory hyperpigmentation is limited.
- Trial name
- NCT05206318
- Testing
- Topical Cysteamine, Topical Vehicle Control
- Where
- Taiwan
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Chang Gung Memorial Hospital